Replacement aortic heart valve failure can lead to severe complications, including heart failure, stroke, or even death. If you or a loved one suffered harm due to a defective replacement aortic valve – like the ones made by Abbott Laboratories or a number of other medical device companies – you may have grounds for a lawsuit. These devices have been linked to catastrophic failures, including leaks, fractures, and more, putting patients at unnecessary risk. Phillips Law Group may be able to assist you with an aortic heart valve failure lawsuit, following a comprehensive evaluation with a member of our team.
Replacement Aortic Heart Valve Failures
Manufacturers have a duty to ensure their medical devices are safe and effective. When they cut corners, mislead the public, or fail to warn of known risks, they must be held accountable.
Recent concerns over the oversight of replacement heart valve safety – and whether some companies that manufacture and market these devices prioritized profits over patient well-being – have, in some cases, led to patients taking legal action with the help of personal injury lawyers. If you believe your replacement aortic heart valve was faulty, or that the device given to a loved one was defective and led to complications, you may be able to pursue a lawsuit.
If you experienced any of the following complications after getting a heart valve replacement device, please contact our firm without delay:
- Valve failure
- Valve leakage
- Stroke
- Blood clots
- Heart failure
- Repeat surgeries
- …and more
FDA Warns of Valve Deterioration Risks
In February 2023, the United States Food and Drug Administration (FDA) warned of a potential risk of early structural valve deterioration with Abbott Trifecta valves.
“The U.S. Food and Drug Administration (FDA) is informing health care providers about the potential risk of early structural valve deterioration (SVD) with Abbott Trifecta valves, including the Trifecta Valve and the Trifecta Valve with Glide Technology (Trifecta GT), which feature leaflets externally mounted to the valve frame,” a letter to healthcare providers posted online by the FDA revealed.
“Information from published literature suggests a higher cumulative incidence of early (five years or less) SVD for Trifecta valves compared to other commercially available surgical bioprosthetic valves.”
The letter recommended that patients who had undergone implantation with Trifecta valves should be monitored “for signs and symptoms of potential SVD.”
Although Abbott announced its decision to stop selling and distributing Trifecta valves – including theTrifecta Valve and the Trifecta Valve with Glide Technology (Trifecta GT) – in the United States in July 2023, there could still be impacted patients out there, or patients who have suffered complications from aortic heart valve failure with the use of other defective heart valve devices.
Defective Aortic Heart Valve Lawsuits
Our experienced attorneys fight aggressively for victims of defective medical devices, including replacement aortic valve failures. Our team works hard to secure justice through settlements or verdicts for our clients who have suffered due to malpractice, negligence, and more.
Let us help you demand accountability from negligent manufacturers while you focus on healing. Call us today for a free, confidential, no-obligation case review. If your aortic heart valve replacement device failed due to a defect, you deserve answers…and justice.
Please don’t hesitate to contact us at 602-222-2222 to learn more now.
Available 24/7